-+ 0.00%
-+ 0.00%
-+ 0.00%

Aardvark Therapeutics held annual shareholder meeting

PUBT·08/17/2026 20:11:06
Listen to the news
Aardvark Therapeutics held annual shareholder meeting
  • Aardvark Therapeutics held its 2026 annual shareholder meeting on Aug. 14, 2026.
  • Shareholders ratified BDO USA as independent auditor for the year ending Dec. 31, 2026.
  • Investors also backed a repricing of certain outstanding stock options under the 2017 Plan, 2025 Plan, and 2025 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-354053), on August 17, 2026, and is solely responsible for the information contained therein.